Literature DB >> 9573102

A 70-kilodalton recombinant heat shock protein of Candida albicans is highly immunogenic and enhances systemic murine candidiasis.

C Bromuro1, R La Valle, S Sandini, F Urbani, C M Ausiello, L Morelli, C Fé d'Ostiani, L Romani, A Cassone.   

Abstract

The 70-kDa recombinant Candida albicans heat shock protein (CaHsp70) and its 21-kDa C-terminal and 28-kDa N-terminal fragments (CaHsp70-Cter and CaHsp70-Nter, respectively) were studied for their immunogenicity, including proinflammatory cytokine induction in vitro and in vivo, and protection in a murine model of hematogenous candidiasis. The whole protein and its two fragments were strong inducers of both antibody (Ab; immunoglobulin G1 [IgG1] and IgG2b were the prevalent isotypes) and cell-mediated immunity (CMI) responses in mice. CaHsp70 preparations were also recognized as CMI targets by peripheral blood mononuclear cells of healthy human subjects. Inoculation of CaHsp70 preparations into immunized mice induced rapid production of interleukin-6 (IL-6) and tumor necrosis factor alpha, peaking at 2 to 5 h and declining within 24 h. CaHsp70 and CaHsp70-Cter also induced gamma interferon (IFN-gamma), IL-12, and IL-10 but not IL-4 production by CD4+ lymphocytes cocultured with splenic accessory cells from nonimmunized mice. In particular, the production of IFN-gamma was equal if not superior to that induced in the same cells by whole, heat-inactivated fungal cells or the mitogenic lectin concanavalin A. In immunized mice, however, IL-4 but not IL-12 was produced in addition to IFN-gamma upon in vitro stimulation of CD4+ cells with CaHsp70 and CaHsp70-Cter. These animals showed a decreased median survival time compared to nonimmunized mice, and their mortality was strictly associated with organ invasion by fungal hyphae. Their enhanced susceptibility was attributable to the immunization state, as it did not occur in congenitally athymic nude mice, which were unable to raise either Ab or CMI responses to CaHsp70 preparations. Together, our data demonstrate the elevated immunogenicity of CaHsp70, with which, however, no protection against but rather some enhancement of Candida infection seemed to occur in the mouse model used.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9573102      PMCID: PMC108176          DOI: 10.1128/IAI.66.5.2154-2162.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.

Authors:  M J Gomez; A Torosantucci; S Arancia; B Maras; L Parisi; A Cassone
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Members of the Hsp70 family of proteins in the cell wall of Saccharomyces cerevisiae.

Authors:  J L López-Ribot; W L Chaffin
Journal:  J Bacteriol       Date:  1996-08       Impact factor: 3.490

3.  Evidence for presence in the cell wall of Candida albicans of a protein related to the hsp70 family.

Authors:  J L López-Ribot; H M Alloush; B J Masten; W L Chaffin
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

4.  A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.

Authors:  A Mencacci; A Torosantucci; R Spaccapelo; L Romani; F Bistoni; A Cassone
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

5.  Molecular cloning and expression of a 70-kilodalton heat shock protein of Candida albicans.

Authors:  R La Valle; C Bromuro; L Ranucci; H M Muller; A Crisanti; A Cassone
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

6.  A single mycobacterial protein (hsp 65) expressed by a transgenic antigen-presenting cell vaccinates mice against tuberculosis.

Authors:  C L Silva; D B Lowrie
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

Review 7.  Hsp70 in parasites: as an inducible protective protein and as an antigen.

Authors:  B Maresca; G S Kobayashi
Journal:  Experientia       Date:  1994-11-30

8.  Antibody response that protects against disseminated candidiasis.

Authors:  Y Han; J E Cutler
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

9.  TGF-beta is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans.

Authors:  R Spaccapelo; L Romani; L Tonnetti; E Cenci; A Mencacci; G Del Sero; R Tognellini; S G Reed; P Puccetti; F Bistoni
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

10.  Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans.

Authors:  L Romani; A Mencacci; E Cenci; R Spaccapelo; C Toniatti; P Puccetti; F Bistoni; V Poli
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  20 in total

Review 1.  Heat shock proteins in immune reactions.

Authors:  E Weigl; P Kopecek; M Raska; S Hradilová
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

2.  Molecular characterization of genes encoding cytosolic Hsp70s in the zygomycete fungus Rhizopus nigricans.

Authors:  Bostjan Cernila; Bronislava Cresnar; Katja Breskvar
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

3.  Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.

Authors:  M J Gomez; B Maras; A Barca; R La Valle; D Barra; A Cassone
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 4.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

5.  Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality.

Authors:  Rafael Zaragoza; Javier Pemán; Guillermo Quindós; Jose R Iruretagoyena; María S Cuétara; Paula Ramírez; Maria D Gómez; Juan J Camarena; Angel Viudes; José Pontón
Journal:  Clin Vaccine Immunol       Date:  2009-08-12

6.  Prediction of the clinical outcome in invasive candidiasis patients based on molecular fingerprints of five anti-Candida antibodies in serum.

Authors:  Aida Pitarch; César Nombela; Concha Gil
Journal:  Mol Cell Proteomics       Date:  2010-09-21       Impact factor: 5.911

7.  The relevance of heat shock regulation in fungal pathogens of humans.

Authors:  Alistair J P Brown; Michelle D Leach; Susan Nicholls
Journal:  Virulence       Date:  2010 Jul-Aug       Impact factor: 5.882

8.  The Pathophysiology and Treatment of Candida Sepsis.

Authors:  Brad Spellberg; John E. Edwards
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

9.  Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Authors:  Carla Bromuro; Antonella Torosantucci; Paola Chiani; Stefania Conti; Luciano Polonelli; Antonio Cassone
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.

Authors:  María D Moragues; Miren J Omaetxebarria; Natalia Elguezabal; María J Sevilla; Stefania Conti; Luciano Polonelli; José Pontón
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.